Clave

Investor type

VC

Founded

2002

AUM

$90 M

Location

Pamplona, Navarre, Spain

Investment Ticket

$10-50 m

Investment Stage

Series A Seed Series B Late Stage (Series C+)

Region of investment

Europe
Investor profile last updated: 16 August, 2026

Profile

Clave is a venture capital firm based in Pamplona, Spain, with 20 years of experience. The firm was founded with a focus on driving technological transfer projects, industrial SMEs, and renewable energy projects. The firm has made over 90 investments and currently manages approximately €90 million. Clave emphasizes close collaboration with promoters, management teams, investors, and the innovation ecosystem to support the growth of companies and tackle new market challenges. The team, comprising experienced professionals from various backgrounds, brings a wealth of expertise to its portfolio companies.

Clave invests primarily in sectors such as healthcare, medtech, ehealth, nutrition, and biotech, with a geographical focus on Europe. The firm recently launched a new Tech Transfer Health Fund worth €80 million, backed by CDTI’s INNVIERTE program and other private investors. Clave targets diverse stages, mainly focusing on tech transfer and early to growth stage investments. It strategically partners with institutions and investors to leverage its funds and expertise to support innovative ideas and business growth.

Notable investments include EverSens - respiratory health diagnostics, Innoprick - healthcare solutions, Abanza Tecnomed - medical devices, Polimerbio - biodegradable polymers, and Predictheon - predictive diagnostics. Clave supports these and other companies through active involvement and strategic guidance, ensuring they are well-positioned for future growth.

Industry

Biotechnology Business Services (B2B) Construction Financial Services Fintech Food and Beverage Foodtech Healthcare Services Industrial IT Services Other MedTech HealthTech

Clave Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Tech Transfer Health Fund
Venture Capital (VC)
Biotechnology
Foodtech
MedTech
HealthTech
Series A
Late Stage (Series C+)
Europe
$10-50 m
September 2026

Contacts

Name
Title
Email
avatar
Alberto Bermejo Urieta Investment Director
Investment Director
b•••@•••
avatar
Francisco Montero Pejenaute Director Financiero Administrativo
Director Financiero Administrativo
m•••@•••
Upgrade to see contacts
avatar
zAl7trEOQnZGPj94 zAl7trEOQnZGPj94
zAl7trEOQnZGPj94
avatar
zAl7trEOQnZGPj94 zAl7trEOQnZGPj94
zAl7trEOQnZGPj94
avatar
zAl7trEOQnZGPj94 zAl7trEOQnZGPj94
zAl7trEOQnZGPj94
Investment-team contacts for Clave — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Clave

Clave is a venture capital firm. It backs companies at Series A, Seed, Series B and Late Stage (Series C+), writing tickets of $10-50 m.
Clave is located in Pamplona, Navarre, Spain.
Clave was founded in 2002.
Clave invests in companies and startups in Biotechnology, Business Services (B2B), Construction, Financial Services, Fintech, Food and Beverage, Foodtech, Healthcare Services, Industrial, IT Services, Other, MedTech, HealthTech.
Clave invests in companies and startups in Europe.
Clave invests in companies and startups at Series A, Seed, Series B, Late Stage (Series C+).
Clave usually invests $10-50 m on average.
Clave has around $90m assets under management.
Clave can be reached through its website clave.capital, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Clave — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Clave directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.